- English (USA)
- English (UK)
- English (India)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Português (Portugal)
- Polski
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Agilent Technologies Inc (A)Agilent Technologies Inc stock price live, this page displays NYSE A stock exchange data. View the A premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Agilent Technologies Inc real time stock price chart below.
What Is the Agilent Technologies Inc Stock Price Today?
The Agilent Technologies Inc stock price today is 139.00.
What Is the Stock Symbol for Agilent Technologies Inc?
The stock symbol for Agilent Technologies Inc is "A."
What Stock Exchange Does Agilent Technologies Inc Trade On?
Agilent Technologies Inc is listed and trades on the NYSE stock exchange.
Is Agilent Technologies Inc a Good Stock to Buy?
Determining whether Agilent Technologies Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the A quote. (ISIN: US00846U1016)
What Is the Agilent Technologies Inc Stock Price Today?
The Agilent Technologies Inc stock price today is 139.00.
What Is the Stock Symbol for Agilent Technologies Inc?
The stock symbol for Agilent Technologies Inc is "A."
What Stock Exchange Does Agilent Technologies Inc Trade On?
Agilent Technologies Inc is listed and trades on the NYSE stock exchange.
Is Agilent Technologies Inc a Good Stock to Buy?
Determining whether Agilent Technologies Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the A quote. (ISIN: US00846U1016)
139.00
-1.91(-1.36%)
Closed
After Hours
138.44-0.56(-0.40%)
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
137.29
140.47
52 wk Range
124.16
155.35
A Scorecard
Full Analysis
Management has been aggressively buying back shares
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
137.29140.47
52 wk Range
124.16155.35
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(0.71%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(0.71%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
A Scorecard
Company’s Health
Assesses a company's financial position by analyzing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceFair Price
Upside
Price Target
148.64
Upside
+6.94%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
10 analysts have revised their earnings downwards for the upcoming period
- Agilent shares reiterate Buy rating on earnings beat
- Investing.com
- Agilent tech receives Investment Bank Analyst Rating Update
- Investing.com
Pro
Agilent Technologies Inc Company Profile
Agilent Technologies, Inc. provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies. The Diagnostics and Genomics segment focuses on genomics, nucleic acid contract manufacturing and research and development, pathology, companion diagnostics, reagent partnership, and biomolecular analysis businesses. The Agilent CrossLab segment provides GC and LC columns, sample preparation products, custom chemistries, and laboratory instrument supplies; and offers services portfolio, including repairs, parts, maintenance, installations, training, compliance support, software as a service, asset management, and consulting services. The company markets its products through direct sales, distributors, resellers, manufacturer's representatives, and electronic commerce. Agilent Technologies, Inc. was incorporated in 1999 and is headquartered in Santa Clara, California.
Agilent Technologies Inc SWOT Analysis
Strategic Expansion | Agilent's $925M Biovectra acquisition marks a significant move into the CDMO sector, enhancing its biopharma solutions capabilities and market position |
Market Headwinds | Explore Agilent's response to recent challenges, including revised guidance due to pharmaceutical segment shifts and China market uncertainties |
Analyst Perspectives | Diverse analyst opinions reflect Agilent's complex market position, with price targets ranging from $135 to $163, highlighting varied growth expectations |
Future Growth Drivers | Delve into Agilent's potential catalysts, including anticipated instrument demand acceleration, PFAS testing market leadership, and biopharma sector preferences |
A Full Pro Research
Institutional-Grade Stock Analysis
Understand how A earns money
Financial health at a glance
Bearish and bullish outlooks
Latest expert insights
Actionable Pro Tips, and many more...
Gain access to 1400+ in-depth research reports on the most popular US stocks
Agilent Technologies Inc Earnings Call Summary for Q3/2024
- Q3 revenue at $1.578B, down 4.4% YoY; EPS at $1.32, beating guidance by $0.04; operating margin improved to 27.4%
- Acquisitions of BIOVECTRA and Sigsense completed to enhance capabilities in key growth areas
- Full-year revenue guidance raised to $6.450B-$6.500B; EPS outlook increased to $5.21-$5.25
- Q4 revenue expected at $1.641B-$1.691B; EPS projected between $1.38-$1.42, indicating growth at midpoint
- China revenue down 11% but showing sequential improvement; company expects return to growth in Q4 and into 2025
Last Updated: 2024-08-22, 12:52 p/m
Read Full TranscriptCompare A to Peers and Sector
Metrics to compare | A | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipAPeersSector | |
|---|---|---|---|---|
P/E Ratio | 30.8x | −3.1x | −0.6x | |
PEG Ratio | 5.34 | −0.25 | 0.00 | |
Price/Book | 6.7x | 1.2x | 2.6x | |
Price / LTM Sales | 6.1x | 5.1x | 3.2x | |
Upside (Analyst Target) | 8.5% | 58.2% | 49.4% | |
Fair Value Upside | Unlock | 21.5% | 7.8% | Unlock |
Analysts' Recommendations
9 Buy
10 Hold
1 Sell
Ratings:
17 analysts
Overall Consensus
Buy
Analysts 12-Month Price Target:
Average 148.64
(+6.94% Upside)
Dividends
Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 4.44
Dividend Yield
0.70%
Industry Median 0.73%
Annualized payout
0.9920
Paid quarterly
5-Years Growth
+7.55%
Growth Streak
People Also Watch
FAQ
What Is the Agilent Technologies (A) Stock Price Today?
The Agilent Technologies stock price today is 139.00
What Stock Exchange Does Agilent Technologies Trade On?
Agilent Technologies is listed and trades on the NYSE stock exchange.
What Is the Stock Symbol for Agilent Technologies?
The stock symbol for Agilent Technologies is "A."
Does Agilent Technologies Pay Dividends? What’s The Current Dividend Yield?
The Agilent Technologies dividend yield is 0.71%.
What Is the Agilent Technologies Market Cap?
As of today, Agilent Technologies market cap is 39.67B.
What is Agilent Technologies Earnings Per Share?
The Agilent Technologies EPS is 4.44.
What Is the Next Agilent Technologies Earnings Date?
Agilent Technologies will release its next earnings report on Feb 25, 2025.
From a Technical Analysis Perspective, Is A a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Buy.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.